Partnership for life 2018

LMI and partners welcome you to join this day where we will present the Norwegian life science ecosystem, discuss the importance of collaboration, look at global success stories and challenge Norwegian decision and policy makers on their ambition and execution.

Time and place: – , Latter, Oslo Aker brygge

Swipe on the arrows on the pictures in the image carousel below to see pictures from the event.

include:image-listing: resource not found: /english/research/strategic-research-areas/life-science/oslo-life-science-2018/pictures/partnership-for-life

Innovation and value creation within the life sciences demands excellence in science, quality healthcare services with capacity and a culture for public-private research projects, high amount of investments, skilled business development and brilliant people.

An ecosystem that embraces this, is the key to achieve high competitiveness and results in benefits for patients, society and businesses.

Moderator through the day: Anne Grosvold

Program

10.00–10.15 The innovation journey – from idea to product

Welcome

Karita Bekkemellem, CEO, LMI

10.15–11.15 The Norwegian ecosystem

Introducing Oslo – a life science city

Marius ?gaard, CEO, The Life Science Cluster

Building the life science city

Per Morten Sandset, Vice-Rector Research and Innovation, University of Oslo

SPARK Norway – building a life science powerhouse and boosting academic entrepreneurship

Morten Egeberg, Administrative Leader, UiO:Life Science

ShareLab – Oslo’s new biotech incubator

Esben A. Nilssen, CEO, ShareLab

Life science investment opportunities in the Nordics

Ingrid Teigland Akay, Hadean Ventures

What’s it like to start a life science company in Oslo today?

Agnete Brunsvik Fredriksen, CSO, Vaccibody

Dialog – is the eco system for innovation improving?

  • Agnete B. Fredriksen, Vaccibody
  • Per Morten Sandset, Vice-Rector Research and Innovation, University of Oslo
  • Esben A. Nilssen, CEO, ShareLab
  • Ingrid Takay, Haydean Venture

11.15-12.15 The importance of public–private collaboration

  • Dr. Sabine Jaccaud, Director, Cambridge Communications, AstraZeneca
  • Laszlo Kiss, Executive Director Pfizer, Inc
  • Kevin J. Lynch, Ph.D. Vice President Head, Search and Evaluation, AbbVie
  • Tarja Jalava, PhD Head Clinical Project Management, Bayer

12.15–12.45 Lunch break

12.45–13.45 Global success stories

G?teborg Life Science Centrum

Anna Maria Fuxén, Vice president, GoCo Gothenburg

Novo Nordisk Bio Innovation Insitute

Mikkel Bülow Skovborg, Senior Officer, Novo Nordisk Foundation

Dialog – How does Norway compare to global initiatives?

13.45–14.00 Short break

14.00–15.00 Ambitions and goals for Norwegian Life science and Health and Care services

This session will be in Norwegian!

Oppspill til debatt

Torgeir Michaelsen. former politician Ap

Debate

  • Sveinung Stensland, H 
  • Ingvild Kjerkol, AP
  • Carl-Erik Grimstad, V
  • Lena Nymo Helli, CEO AbbVie
  • Karita Bekkemellem, CEO, LMI

14.00–17.00 One-to-one meetings – Find your future partner! 

For the first time at Partnership for life will organize a one-to-one meeting session where we invite companies, startups, investors and academia. The session is facilitated by Inven2. academia. Sign up for partnering meetings.

  • Expand your knowledge
  • Exchange competence
  • Extend your network
  • Identify possible areas for collaboration

15.00–18.00 Refreshments and social interaction

Organizer

The Association of the Pharmaceutical Industry in Norway (LMI) and partners: Bayer, AstraZeneca, Abbvie, Pfizer and The life science cluster
Published June 23, 2017 12:52 PM - Last modified Jan. 10, 2023 5:11 PM
E-mail this page